Department of Clinical Pharmacy & Therapeutics, Faculty of Pharmacy, Applied Science Private University, Amman, Jordan.
Department of Internal Medicine, Faculty of Medicine, University of Jordan, Respiratory and sleep Medicine, Jordan University Hospital, Amman, Jordan.
NPJ Prim Care Respir Med. 2017 Feb 9;27(1):9. doi: 10.1038/s41533-017-0011-4.
Inhaler technique can be corrected with training, but skills drop off quickly without repeated training. The aim of our study was to explore the effect of novel inhaler technique labels on the retention of correct inhaler technique. In this single-blind randomized parallel-group active-controlled study, clinical pharmacists enrolled asthma patients using controller medication by Accuhaler [Diskus] or Turbuhaler. Inhaler technique was assessed using published checklists (score 0-9). Symptom control was assessed by asthma control test. Patients were randomized into active (ACCa; THa) and control (ACCc; THc) groups. All patients received a "Show-and-Tell" inhaler technique counseling service. Active patients also received inhaler labels highlighting their initial errors. Baseline data were available for 95 patients, 68% females, mean age 44.9 (SD 15.2) years. Mean inhaler scores were ACCa:5.3 ± 1.0; THa:4.7 ± 0.9, ACCc:5.5 ± 1.1; THc:4.2 ± 1.0. Asthma was poorly controlled (mean ACT scores ACCa:13.9 ± 4.3; THa:12.1 ± 3.9; ACCc:12.7 ± 3.3; THc:14.3 ± 3.7). After training, all patients had correct technique (score 9/9). After 3 months, there was significantly less decline in inhaler technique scores for active than control groups (mean difference: Accuhaler -1.04 (95% confidence interval -1.92, -0.16, P = 0.022); Turbuhaler -1.61 (-2.63, -0.59, P = 0.003). Symptom control improved significantly, with no significant difference between active and control patients, but active patients used less reliever medication (active 2.19 (SD 1.78) vs. control 3.42 (1.83) puffs/day, P = 0.002). After inhaler training, novel inhaler technique labels improve retention of correct inhaler technique skills with dry powder inhalers. Inhaler technique labels represent a simple, scalable intervention that has the potential to extend the benefit of inhaler training on asthma outcomes.
REMINDER LABELS IMPROVE INHALER TECHNIQUE: Personalized labels on asthma inhalers remind patients of correct technique and help improve symptoms over time. Iman Basheti at the Applied Science Private University in Jordan and co-workers trialed the approach of placing patient-specific reminder labels on dry-powder asthma inhalers to improve long-term technique. Poor asthma control is often exacerbated by patients making mistakes when using their inhalers. During the trial, 95 patients received inhaler training before being split into two groups: the control group received no further help, while the other group received individualized labels on their inhalers reminding them of their initial errors. After three months, 67% of patients with reminder labels retained correct technique compared to only 12% of controls. They also required less reliever medication and reported improved symptoms. This represents a simple, cheap way of tackling inhaler technique errors.
探讨新型吸入器技术标签对保持正确吸入器技术的影响。
本研究为单盲随机平行组活性对照研究,临床药师招募使用 Accuhaler[Diskus]或 Turbuhaler 进行控制器药物治疗的哮喘患者。使用已发表的检查表(得分为 0-9)评估吸入器技术。通过哮喘控制测试评估症状控制。患者被随机分为活性(ACCa;THa)和对照(ACCc;THc)组。所有患者均接受“演示和讲解”吸入器技术咨询服务。活性患者还接受突出其初始错误的吸入器标签。
共有 95 例患者(68%为女性)纳入基线数据,平均年龄为 44.9(15.2)岁。平均吸入器评分为 Acca:5.3±1.0;THa:4.7±0.9,Accc:5.5±1.1;THc:4.2±1.0。哮喘控制不佳(平均 ACT 评分 Acca:13.9±4.3;THa:12.1±3.9;Accc:12.7±3.3;THc:14.3±3.7)。在训练后,所有患者均采用正确的技术(评分 9/9)。在 3 个月后,与对照组相比,活性组的吸入器技术评分下降幅度明显较小(平均差值:Accuhaler-1.04(95%置信区间-1.92,-0.16,P=0.022);Turbuhaler-1.61(-2.63,-0.59,P=0.003))。症状控制显著改善,活性组与对照组患者之间无显著差异,但活性组患者使用的缓解药物较少(活性组 2.19(1.78)比对照组 3.42(1.83)喷/天,P=0.002)。
在干粉吸入器中使用新型吸入器技术标签可提高正确吸入器技术技能的保留率。吸入器技术标签代表一种简单、可扩展的干预措施,有可能延长吸入器训练对哮喘结果的益处。